Preliminary Cost-effectiveness and Cost-utility of Nasopharyngeal Carcinoma Screening with the Novel Biomarker Anti-BNLF2b Total Antibody
These data could inform the design of NPC screening in China, where targeted screening has the potential to reduce health disparities.
Authors
- Ting Wu (ORCID: https://orcid.org/0000-0002-1806-3056)
- Yue Huang (ORCID: https://orcid.org/0000-0002-0864-8990)
- Shengxiang Ge (ORCID: https://orcid.org/0000-0002-7165-3004)
- Xia Yu (ORCID: https://orcid.org/0000-0002-7701-2822)
- Chunlan Zhuang (ORCID: https://orcid.org/0000-0002-8253-2515)
- Tingdong Li (ORCID: https://orcid.org/0000-0003-0685-2549)
- Mingfang Ji (ORCID: https://orcid.org/0000-0003-4727-2858)
- Jiali Quan (ORCID: https://orcid.org/0000-0001-9089-6856)
- Ningshao Xia (ORCID: https://orcid.org/0000-0003-0179-5266)
- Jun Zhang (ORCID: https://orcid.org/0000-0002-6601-9180)
- Yingying Su (ORCID: https://orcid.org/0000-0003-3883-357X)
- Shoujie Huang (ORCID: https://orcid.org/0000-0001-5012-2274)
- Fan Liu (ORCID: https://orcid.org/0009-0000-2667-6330)
- Jinrong Hao (ORCID: https://orcid.org/0009-0009-0154-4644)
Institutions
- Xiamen University (CN)
- Zhongshan City Second People's Hospital (CN)
- Zhongshan People's Hospital (CN)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1158/1055-9965.epi-25-0648
- Citations
- 1
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47